Literature DB >> 2780005

Mechanisms of intraocular pressure elevation after pars plana vitrectomy.

D P Han1, H Lewis, F H Lambrou, W F Mieler, A Hartz.   

Abstract

A prospective study of 222 consecutive patients undergoing pars plana vitrectomy was done to determine the incidence and mechanisms of postoperative intraocular pressure (IOP) elevation. Within 48 hours of surgery, postoperative IOP increased by at least 5 to 22 mmHg in 136 eyes (61.3%) and to 30 mmHg or more in 79 eyes (35.6%). Presumed mechanisms of open-angle glaucoma included intraocular gas expansion (28.4%), inflammatory trabecular meshwork obstruction (4.5%), silicone oil-related glaucoma (3.6%), and erythroclastic glaucoma (2.2%). Closed-angle mechanisms included pupillary block glaucoma (6.8%) and ciliary body edema (3.6%). Factors which were associated with postvitrectomy pressure elevation included placement of a scleral buckle, either intraoperatively (P = 0.003) or before vitrectomy (P = 0.001), intraoperative scatter endophotocoagulation (P = 0.041), intra-operative lensectomy (P = 0.024), and development of postoperative fibrin membranes (P = 0.038). Surgery was required to lower IOP or relieve pupillary block in 25 eyes (11.3%).

Entities:  

Mesh:

Year:  1989        PMID: 2780005     DOI: 10.1016/s0161-6420(89)32715-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  41 in total

1.  The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation following pars plana vitrectomy with long-acting gas tamponade.

Authors:  R A Mittra; J S Pollack; S Dev; D P Han; W F Mieler; T B Connor
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  [Glaucoma and retinal surgery].

Authors:  M Müller; G Geerling; M Zierhut; T Klink
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

3.  Intraocular pressure elevation in the early postoperative period after vitrectomy for rhegmatogenous retinal detachment.

Authors:  Yumi Hasegawa; Fumiki Okamoto; Yoshimi Sugiura; Yoshifumi Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Jpn J Ophthalmol       Date:  2012-01       Impact factor: 2.447

4.  Vitrectomy does not increase the risk of open-angle glaucoma or ocular hypertension--a 5-year follow-up.

Authors:  Alice L Yu; Wolfgang Brummeisl; Markus Schaumberger; Anselm Kampik; Ulrich Welge-Lussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-20       Impact factor: 3.117

5.  25-, 23-, and 20-gauge vitrectomy in epiretinal membrane surgery: a comparative study of 553 cases.

Authors:  Otman Sandali; Mohamed El Sanharawi; Nicolas Lecuen; Pierre-Olivier Barale; Sebastien Bonnel; Elena Basli; Vincent Borderie; Laurent Laroche; Claire Monin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-10       Impact factor: 3.117

6.  Effectiveness of apraclonidine 1% in preventing intraocular pressure rise following macular hole surgery.

Authors:  A Sciscio; A G Casswell
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

Review 7.  Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Authors:  Jaafar El Annan; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

8.  Clinical results of selective laser trabeculoplasty in silicone oil-induced secondary glaucoma.

Authors:  Miaomiao Zhang; Bin Li; Jianrong Wang; Wei Liu; Yan Sun; Xinyi Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-27       Impact factor: 3.117

9.  Intraocular pressure changes after vitrectomy with and without combined phacoemulsification and intraocular lens implantation.

Authors:  Hee Kyung Yang; Se Joon Woo; Kyu Hyung Park; Ki Ho Park
Journal:  Korean J Ophthalmol       Date:  2010-11-23

10.  Impact of early rise of intraocular pressure on visual outcome following diabetic vitrectomy.

Authors:  Yog Raj Sharma; Archna Pruthi; Raj Vardhan Azad; Atul Kumar; Rashim Mannan
Journal:  Indian J Ophthalmol       Date:  2011 Jan-Feb       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.